ZYNLONTA

Serial Number 97571344
Registration 7403109
700

Registration Progress

Application Filed
Aug 30, 2022
Under Examination
Sep 19, 2023
Approved for Publication
Jul 25, 2023
Published for Opposition
Jul 25, 2023
Registered
May 28, 2024

Trademark Image

ZYNLONTA

Basic Information

Serial Number
97571344
Registration Number
7403109
Filing Date
August 30, 2022
Registration Date
May 28, 2024
Published for Opposition
July 25, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 28, 2024
Registration
Registered
Classes
005 044

Rights Holder

ADC Therapeutics SA

99
Address
Route de la Corniche, 3B
Epalinges 1066
CH

Ownership History

ADC Therapeutics SA

Original Applicant
99
Epalinges CH

ADC Therapeutics SA

Owner at Publication
99
Epalinges CH

ADC Therapeutics SA

Original Registrant
99
Epalinges CH

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

Next Deadline
1772 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-28)
Due Date
May 28, 2030
Grace Period Ends
November 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
May 28, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 28, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 25, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 25, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 3, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 3, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 13, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 13, 2024 IUAF S USE AMENDMENT FILED Loading...
Sep 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 25, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 25, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 5, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 16, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 16, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 16, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 16, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 16, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 15, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 1, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Sep 20, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 18, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 2, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
First Use Anywhere: Dec 6, 2023
First Use in Commerce: Dec 6, 2023
Class 044
providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health
First Use Anywhere: May 11, 2021
First Use in Commerce: May 11, 2021

Additional Information

Design Mark
The mark consists of the wording "Zynlonta" in fuchsia and brown followed by a design having three brown bars extending from a central fuchsia diamond, with a smaller brown diamond positioned at the end of each bar, and a brown circle that intersects all three bars
Color Claim
The color(s) fuchsia and brown is/are claimed as a feature of the mark.

Classification

International Classes
005 044